-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Putting Your Stamp on the Next Generation of Care in CML: Improving Outcomes from Frontline to R/R Treatment Settings

Sponsor: Ascentage Pharma and Novartis Pharmaceuticals Corporation
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Diseases, Therapies, Adverse Events, Biological Processes
Friday, December 8, 2023: 3:00 PM-6:00 PM
Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
Jorge Cortes, MD, Augusta University
Cortes: Gilead: Consultancy; Takeda: Consultancy, Honoraria; Abbvie: Consultancy, Research Funding; Pfizer: Consultancy, Research Funding; Forma Therapuetic: Consultancy; Biopath Holdings: Consultancy, Current holder of stock options in a privately-held company, Membership on an entity's Board of Directors or advisory committees, Research Funding; Novartis: Consultancy, Research Funding.
Andreas Hochhaus, MD, Universitätsklinikum Jena and Amanda Rodriguez, PA-C, Moffitt Cancer Center
Hochhaus: Incyte: Research Funding; Novartis: Consultancy, Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; Pfizer: Research Funding; Takeda: Consultancy, Research Funding.
The live activity will feature a series of didactic presentations coupled with case-based panel discussions and question-and-answer sessions from the audience. Using a blended instructional model of didactic presentations and interactive panel discussions is intended is to improve medical practices and patient care through evidence-based presentations, discussion, and authoritative peer-exchange on important clinical issues. The satellite program will bring together clinical experts to highlight novel agents in the management of frontline and R/R CML, including the latest clinical data and application of novel TKIs and next-generation treatment approaches, including best practices for monitoring and managing adverse events with a multidisciplinary team in the United States and around the world! Considerations for advanced practice professionals, pharmacists and community clinicians will also be addressed throughout the educational event. Based on positive feedback from attendees at the 2022 ASH Friday Satellite Symposia, each presentation will follow with question-and-answer discussion from the floor.